"Together we will deliver novel CAR T‑cell therapeutics rapidly to change outcomes for patients with advanced solid tumors," says @generate_biomed's Dr. Snyder. Exciting possibilities from this collaboration!
“Early results from an experimental #cancer#vaccine show the potential to delay recurrence and double life expectancy.” Hear from the @roswellpark experts who developed SurVaxM, and from a man with #glioblastoma and his daughter, a nurse. @NBCNightlyNews
https://t.co/9005RitRqH
NEW: An experimental vaccine designed to delay the progression of the deadliest form of brain cancer, glioblastoma, nearly doubled the survival time of patients in an early clinical trial.
https://t.co/AhP6dVPKr5
A pioneer in cell-based treatment for leukemia with more than 25 years of experience, Dr. Peter Maslak, MD joins Roswell Park as our Vice Chair of Clinical Affairs and Technical Director of the Clinical Flow Cytometry Laboratory. https://t.co/27eQcHe1eL
Today is Carly’s birthday.💛
She would have been 32 years old today. Carly didn’t wait to make her mark on the world, she started when she was 9 years old, battling pediatric cancer. Happy birthday, Carly! Thank you for the opportunity to continue your legacy. #CCF
Today marked another milestone in the Roswell Park Scott Bieler Amherst Center. The letters for “Scott Bieler Amherst Center” on @RoswellPark newest building were placed. We are endlessly grateful to Scott & Kathy Bieler and @WestHerr for their steadfast support of our mission!
If you haven’t heard November 12 we will be celebrating the retirement of our Founder Tim Herzog !!! Please join us in raising a pint to honor Tim & all he has done not only for the beer community but our community at large.